(Q38412277)

2 September 2017

1 reference

title

Health economics and outcomes methods in risk-based decision-making for blood safety (English)

1 reference

2 September 2017

1 reference

Brian Custer

1

1 reference

2 September 2017

Mart P Janssen

series ordinal

2

1 reference

2 September 2017

Alliance of Blood Operators Risk-Based Decision-Making (RBDM) Initiative

series ordinal

3

1 reference

2 September 2017

publication date

9 April 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

55

1 reference

2 September 2017

issue

8

1 reference

2 September 2017

page(s)

2039-2047

1 reference

Risk-based decision-making for blood safety: preliminary report of a consensus conference

2 September 2017

cites work

1 reference

Proceedings of a consensus conference: Risk-Based Decision Making for Blood Safety

21 January 2018

1 reference

Best practices in regulation of blood and blood products

21 January 2018

1 reference

Resolving the tension between population health and individual health care

21 January 2018

1 reference

Cost-effectiveness of additional blood screening tests in the Netherlands.

21 January 2018

1 reference

The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model

21 January 2018

1 reference

Costs, consequences, and cost-effectiveness of strategies for Babesia microti donor screening of the US blood supply

21 January 2018

1 reference

Costs and benefits of bacterial culturing and pathogen reduction in the Netherlands.

21 January 2018

1 reference

Modeling the transmission risk of emerging infectious diseases through blood transfusion

21 January 2018

1 reference

Estimating the transfusion transmission risk of Q fever

21 January 2018

1 reference

A framework for applying the precautionary principle to transfusion safety

21 January 2018

1 reference

Risk assessment and cost-effectiveness/utility analysis

21 January 2018

1 reference

Economic analyses of blood safety and transfusion medicine interventions: a systematic review

21 January 2018

1 reference

Cost-effectiveness analysis: what it really means for transfusion medicine decision making

21 January 2018

1 reference

Establishing a framework: economic evaluations in transfusion medicine, part 2.

21 January 2018

1 reference

Pharmaco-economics of blood transfusion safety: review of the available evidence

21 January 2018

1 reference

Health economics of blood transfusion safety--focus on sub-Saharan Africa

21 January 2018

1 reference

Public healthcare resource allocation and the Rule of Rescue.

21 January 2018

1 reference

Eliciting preferences for prioritizing treatment of rare diseases: the role of opportunity costs and framing effects

21 January 2018

1 reference

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

21 January 2018

1 reference

Developing guidance for budget impact analysis

21 January 2018

1 reference

Utilitarianism and the measurement and aggregation of quality--adjusted life years.

21 January 2018

1 reference

Report triggers quibbles over QALYs, a staple of health metrics.

21 January 2018

1 reference

On individual preferences and aggregation in economic evaluation in healthcare

21 January 2018

1 reference

Measures of efficiency in healthcare: QALMs about QALYs?

21 January 2018

1 reference

Good evidence begets good policy: or so it should be.

21 January 2018

1 reference

Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.

21 January 2018

1 reference

Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.

21 January 2018

1 reference

Markov models in medical decision making: a practical guide.

21 January 2018

1 reference

An introduction to Markov modelling for economic evaluation

21 January 2018

1 reference

Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis.

21 January 2018

1 reference

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7.

21 January 2018

1 reference

Building better models: if we build them, will policy makers use them? Toward integrating modeling into health care decisions

21 January 2018

1 reference

Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2.

21 January 2018

1 reference

Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making.

21 January 2018

1 reference

Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland

21 January 2018

1 reference

Expert elicitation for the judgment of prion disease risk uncertainties

21 January 2018

1 reference

The PROTON study: profiles of blood product transfusion recipients in the Netherlands

21 January 2018

1 reference

Blood transfusion utilization and recipient survival at Hospital das Clinicas in São Paulo, Brazil

21 January 2018

1 reference

Survival after transfusion as assessed in a large multistate US cohort.

21 January 2018

1 reference

Survival after blood transfusion

21 January 2018

1 reference

Uncertainty in the environmental modelling process – A framework and guidance

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TRF.13080

1 reference

2 September 2017

1 reference